DEP phase 2 trials - patience required!, page-2

Gumnut,
You have been posting here for one year. Only one year. I don't know how long you have been a shareholder. Some posters on HC have been shareholders for  ten, fifteen, twenty years. And so far, they have patiently received nothing in return.
Most of what you write regarding the technical side of the DEP program is, in my opinion,  correct. But there are two major failings of management that cannot be ignored, especially with the quarterly cash report next week and the AGM next month. Firstly,  it is fair to say that condom coatings, Vivagel and Viraleze are all commercial failures. Many people have lost a lot of money over the past year, and that failure falls directly at managements feet. They must not be rewarded for this failure. Secondly, they have failed to meet their own completion dates for the DEP program, which most long term investors have been patiently waiting for. Follow some of the posts of @col69 to understand what we have been advised by management and how it has all failed to materialise.
How can investors believe what this management say any more?  Just this week they have had to issue an ASX addendum  to add “supplementary information” that put the Italian Viraleze deal in a totally different light.
I for one do not believe they are competent to commercialise DEP, based on their past performance, and I think it is time for change before it is too late. I also think they have damaged the integrity of the company. The ill feelings that you have read over the past few months is towards the incumbent management, not the science. When the share price more than halves are you surprised?